The pro-apoptotic role of secreted forms of FasL and TRAIL in hepatocellular carcinoma has been reported [32-34], though there are contradictory reports suggesting an anti-apoptotic role of secreted FasL [35-37]. Here, FASLG is linked to hepatocellular carcinoma.